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mTATE-OF-THE-ART PAPER383The Role of miRNAs in Vascular Biologyohn F. O’Sullivan, Kenneth Martin, Noel M. Caplice
icro-ribonucleic acids (miRNAs) are an emerging class of highly conserved, noncoding
mall ribonucleic acids (20 to 25 nucleotides) that regulate gene expression at the post-
ranscriptional level. miRNAs are key regulators of many cellular events, and over 600 human
iRNAs have already been identified. O’Sullivan and colleagues review the biology of
iRNAs with a specific emphasis on their effects on vascular smooth muscle cells (VSMCs).
SMCs are critical for forming stable fibrous caps and neointimal hyperplasia. miRNAs may
ave therapeutic potential for stabilizing plaques and preventing neointimal hyperplasia.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY390Different Mechanisms for Late Stent Thrombosis in SES and PESaku Nakazawa, Aloke V. Finn, Marc Vorpahl, Elena R. Ladich, Frank D. Kolodgie, Renu Virmani
akazawa and colleagues reviewed the histology from over 170 autopsy cases to determine
he etiology of late stent thrombosis (LST) and vascular healing responses in polymeric drug-
luting stents (DES) (sirolimus-eluting stents [SES] and paclitaxel-eluting stents [PES]). The
echanism of LST was different between the 2 platforms; localized strut hypersensitivity for
ES and malapposition secondary to excessive fibrin deposition for PES. Moreover, while
oth DES had near complete strut coverage after 12-months for “on-label” usage, the
ajority of stents placed for “off-label” indications remained unhealed. Differential
echanisms of LST were identified between PES and SES.(continued on page A-20)
JANUARY 25, 2011 (continued) A-20IO
S
A
c
i
i
t
h
r
i
c
C
J
O
C
w
r
O
o
w
s
a
H
A
C
R
S
1
1
I
5
h
W
ENTERVENTIONAL CARDIOLOGY399CKD Patients With Reduced Response to Clopidogrel Are at High Risk After PCIlivier Morel, Soraya El Ghannudi, Laurence Jesel, Bogdan Radulescu, Nicolas Meyer, Marie-Louise Wiesel,
ophie Caillard, Umberto Campia, Bruno Moulin, Christian Gachet, Patrick Ohlmann
lthough both chronic kidney disease (CKD) and impaired platelet responsiveness to
lopidogrel are strong predictors of unfavorable outcomes after percutaneous coronary
ntervention (PCI), it is unknown how the two relate. Morel and colleagues measured platelet
nhibition after clopidogrel with the vasodilator-stimulated phosphoprotein flow cytometry
est. At follow-up, all-cause mortality, cardiac death, and possible stent thrombosis were
igher in CKD than in no CKD patients. Within the CKD group, those with a platelet
eactivity index 61% had higher rates of all of the end points than those with more platelet
nhibition after clopidogrel. In CKD patients, the presence of low platelet response to
lopidogrel is associated with worse outcomes after PCI.ARDIAC PHARMACOLOGY409No Evidence of Interaction Between CCBs and Clopidogrelonas B. Olesen, Gunnar H. Gislason, Mette G. Charlot, Emil L. Fosbøl, Charlotte Andersson, Peter Weeke,
le Ahlehoff, Christian Selmer, Christian Torp-Pedersen, Peter R. Hansen
alcium-channel blockers (CCBs) inhibit a variety of cytochrome P450 enzymes, some of
hich are necessary for the metabolic activation of clopidogrel. Olesen and colleagues
eviewed records from all patients who had a first myocardial infarction (MI) in Denmark.
ver 50,000 patients were included, one-half of which were treated with clopidogrel and
ne-quarter with CCBs. The risk of the composite end point was higher in patients treated
ith CCBs, but the risk was not altered by concomitant clopidogrel use. These results
uggest that the clinical efficacy of clopidogrel is not altered by simultaneous CCB treatment
nd that the potential drug interaction is unlikely to carry clinical significance.EART FAILURE418Worsening Depression Predicts Higher Risk in HF Patientsndrew Sherwood, James A. Blumenthal, Alan L. Hinderliter, Gary G. Koch, Kirkwood F. Adams, Jr,
arla Sueta Dupree, Daniel R. Bensimhon, Kristy S. Johnson, Ranak Trivedi, Margaret Bowers,
obert H. Christenson, Christopher M. O’Connor
herwood and colleagues studied the impact of changes in symptoms of depression over a
-year time period on subsequent clinical outcomes in heart failure (HF) patients. A total of
47 HF outpatients were assessed for depressive symptoms using the Beck Depression
nventory (BDI) at baseline and again 1 year later, and they were followed for a median of
years. Patients whose BDI increased were at higher risk for death or cardiovascular
ospitalization after controlling for baseline depression and established HF risk factors.
orsening symptoms of depression are associated with a worse prognosis in HF patients.
ditorial Comment: Ingrid Connerney, Peter Shapiro, p. 424(continued on page A-21)
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EEART RHYTHM DISORDERS427Meta-Analysis Demonstrates Risk of AF Correlates With Alcohol Consumptionatoru Kodama, Kazumi Saito, Shiro Tanaka, Chika Horikawa, Aki Saito, Yoriko Heianza, Yui Anasako,
ukako Nishigaki, Yoko Yachi, Kaoruko Tada Iida, Yasuo Ohashi, Nobuhiro Yamada, Hirohito Sone
revious observational studies have provided inconsistent results on the relationship between
lcohol consumption and the risk of atrial fibrillation (AF). Kodama and colleagues
erformed a meta-analysis of 14 studies and found that the pooled estimate of AF for the
ighest versus the lowest alcohol intake was 1.51. A linear regression model showed that the
owest risk was with no alcohol consumption, and it increased in a linear fashion.ARDIAC IMAGING437Dynamic 3D Stress CMR Perfusion Imagingobert Manka, Cosima Jahnke, Sebastian Kozerke, Viton Vitanis, Gerard Crelier, Rolf Gebker,
ernhard Schnackenburg, Peter Boesiger, Eckart Fleck, Ingo Paetsch
ynamic 3-dimensional (3D) cardiac magnetic resonance (CMR) perfusion imaging may
mprove the detection of myocardial perfusion deficits compared with traditional 2-dimensional
nalysis. In 146 patients with known or suspected coronary artery disease referred for
ngiography, a 3.0-T magnetic resonance examination was performed including 3D-CMR
erfusion during adenosine. Patients who subsequently underwent stenting had a repeat
MR examination after the procedure. 3D-CMR perfusion resulted in a sensitivity,
pecificity, and diagnostic accuracy of 92%, 74%, and 83% for the detection of coronary
tenoses 50%. The volume percent of myocardium that was hypoperfused was calculated for
very patient and decreased from 14% prior to stenting to 3.2% afterwards.ADIATION THERAPY AND CARDIOVASCULAR DISEASE445Evidence for Late Cardiac Damage of Radiotherapy for Breast CancerLeft-sided BC treated by RT
Right-sided BC treated by RT
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Years after breast cancer diagnosis
0
10
20
30
40
50
5 10 15 20 25 30 35 40 45im Bouillon, Nadia Haddy, Suzette Delaloge, Jean-Remy Garbay, Jerome-Philippe Garsi,
auline Brindel, Abdeddahir Mousannif, Monique G. Lê, Martine Labbe, Rodrigo Arriagada, Eric Jougla,
ean Chavaudra, Ibrahima Diallo, Carole Rubino, Florent De Vathaire
ouillon and colleagues investigated very long-term cardiovascular mortality and its
elationship to the use of radiotherapy for breast cancer. Nearly 5,000 women who survived at
east 5 years after treatment of a breast cancer between 1954 and 1984 were followed up for
ortality through 2003. Almost 10% of the deaths were due to cardiovascular causes.
omen who had received radiotherapy had a 1.76-fold higher risk of dying of cardiac
isease, and the risk was even higher for those who had a left-sided breast cancer compared
ith a right-sided one. This study confirms that radiotherapy, as delivered until the mid-
980s, increases the long-term risk of dying of cardiovascular diseases.
ditorial Comment: Ronald M. Witteles, p. 453(continued on page A-28)
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455utologous Injection of Cardiosphere-Derived Cells
Improves Post-MI Remodeling in Pigshuo-Tsan Lee, Anthony J. White, Satoshi Matsushita, Konstantinos Malliaras, Charles Steenbergen,
iqiang Zhang, Tao-Sheng Li, John Terrovitis, Kristine Yee, Sinan Simsir, Raj Makkar, Eduardo Marba´n
ardiosphere-derived cells (CDCs) are a heterogeneous mix of cells expanded from cardiac
iopsies. Lee and colleagues tested the safety and efficacy of direct injection of CDCs and
heir 3-dimensional precursors, cardiospheres, in a mini-pig model of heart failure post-
yocardial infarction. Eight weeks after injection, ejection fraction was higher than placebo in
oth of the cell-treated groups. Echocardiographic and hemodynamic indexes of efficacy
mproved disproportionately with cardiospheres compared with CDCs or placebo. Direct
njection of cardiospheres or CDCs is safe and effective for porcine ischemic cardiomyopathy,
ut cardiospheres are superior in improving hemodynamics and in attenuating ventricular
emodeling.ditorial Comment: Alan W. Heldman, Juan P. Zambrano, Joshua M. Hare, p. 466RE-CLINICAL RESEARCH
469vidence of a Link Between Calcium Handling
and Lethality of Ryanodine Receptor Mutationsataliya Dybkova, Simon Sedej, Carlo Napolitano, Stefan Neef, Adam G. Rokita, Mark Hünlich,
oan Heller Brown, Jens Kockskämper, Silvia G. Priori, Burkert Pieske, Lars S. Maier
atecholaminergic polymorphic ventricular tachycardia is caused by mutations in the
yR2 gene encoding the cardiac isoform of the sarcoplasmic reticulum Ca2-release
hannel (ryanodine receptor). RyR2 activity is modulated by Ca2/calmodulin-dependent
inase II (CaMKII). Dybkova and colleagues investigated whether increased CaMKII
ctivity would aggravate the lethality of a mutated RyR2 in a double mutant mouse
odel. The results showed that having both mutations increased calcium spark frequency,
elayed afterdepolarizations, and the risk of fatal ventricular arrhythmias. These results
onfirm that altered calcium handling affects the lethality of mutations in RyR2 receptor.
